Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Peers

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Neoplasia (New York, N.Y.)|May 14, 2004
Single dose of the antivascular agent, ZD6126 (N-acetylcolchinol-O-phosphate), reduces perfusion for at least 96 hours in the GH3 prolactinoma rat tumor modelDominick J O McIntyre, Simon P Robinson, Franklyn A Howe, et al.
Metallomics : Integrated Biometal Science|March 18, 2015
Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelatorsDavid G Workman, Andrew Tsatsanis, Frank W Lewis, et al.
Plos One|July 30, 2011
Proteomic biomarkers for acute interstitial lung disease in gefitinib-treated Japanese lung cancer patientsFredrik Nyberg, Atsushi Ogiwara, Chris G Harbron, et al.
Journal of Proteome Research|July 20, 2007
Personalized medicine and proteomics: lessons from non-small cell lung cancerGyörgy Marko-Varga, Atsushi Ogiwara, Toshihide Nishimura, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Neoplasia (New York, N.Y.)|May 14, 2004
Single dose of the antivascular agent, ZD6126 (N-acetylcolchinol-O-phosphate), reduces perfusion for at least 96 hours in the GH3 prolactinoma rat tumor modelDominick J O McIntyre, Simon P Robinson, Franklyn A Howe, et al.
Metallomics : Integrated Biometal Science|March 18, 2015
Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelatorsDavid G Workman, Andrew Tsatsanis, Frank W Lewis, et al.
Plos One|July 30, 2011
Proteomic biomarkers for acute interstitial lung disease in gefitinib-treated Japanese lung cancer patientsFredrik Nyberg, Atsushi Ogiwara, Chris G Harbron, et al.
Journal of Proteome Research|July 20, 2007
Personalized medicine and proteomics: lessons from non-small cell lung cancerGyörgy Marko-Varga, Atsushi Ogiwara, Toshihide Nishimura, et al.
Pageof 2